Table 1.
Summary of the simulation scenarios
| Number of studies | |
| Balanced direct comparisons | KAB = KAC = KBC = 1, …, 7 |
| Imbalanced direct comparisons | KAB = 1, KAC = 4, KBC = 7 (and KAB = 1, KAC = 4, KBC = 3 for the typical loop) |
| Treatment effects | |
| Comparison AB | ORAB = 0.73 |
| Comparison AC | ORAC = 1 |
| Comparison BC | ORBC = exp{log(ORAC) - log(ORAB) + IFABC} |
| Inconsistency in the network | |
| Inconsistency Factor | IFABC = {0, 0.3, 0.45, 0.6, 1} |
| Heterogeneity in the network | |
| Subjective outcome | τ2 ~ LN(-2.13, 1.582) |
| All-cause mortality outcome | τ2 ~ LN(-4.06, 1.452) |
Trial arm size
| |
| Small | n ~ U(20, 50) |
| Moderate | n ~ U(50, 150) |
| Large | n ~ U(150, 300) (and n ~ U(120, 160) for the typical loop) |
| Frequency of events | |
| Average risk for frequent events |
|
| Average risk for rare events |
|
| Approaches to estimate the variances of the direct pairwise summary effects | |
| Inverse variance method | |
| Knapp-Hartung method | |


